新型口服抗凝剂的临床意义：其潜在优势能否实现？ - Suppr

Suppr

超能文献

The clinical implications of new oral anticoagulants: will the potential advantages be achieved?

作者信息

Phillips Katherine W, Ansell Jack

机构信息

Department of Pharmacy, Boston Medical Center, Boston, Massachusetts, USA.

出版信息

Thromb Haemost. 2010 Jan;103(1):34-9. doi: 10.1160/TH09-06-0361. Epub 2009 Dec 1.

DOI:10.1160/TH09-06-0361

PMID:20062925

Abstract

摘要

相似文献

The clinical implications of new oral anticoagulants: will the potential advantages be achieved?

Thromb Haemost. 2010 Jan;103(1):34-9. doi: 10.1160/TH09-06-0361. Epub 2009 Dec 1.

Bleeding complications in patients on anticoagulants who would have been disqualified for clinical trials.

Thromb Haemost. 2008 Dec;100(6):1047-51.

Does a longer duration of oral factor Xa therapy increase the risk of bleeding or transaminitis?

Thromb Res. 2011 Mar;127(3):202-9. doi: 10.1016/j.thromres.2010.11.017. Epub 2010 Dec 14.

Novel oral anticoagulants and diet: the potential for interaction.

Am J Hematol. 2009 Apr;84(4):260-1. doi: 10.1002/ajh.21371.

New oral anticoagulants in development.

Thromb Haemost. 2010 Jan;103(1):62-70. doi: 10.1160/TH09-07-0434. Epub 2009 Oct 26.

Anticoagulant drugs: what is new?

Int Angiol. 2011 Aug;30(4):299-320.

Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.

Cerebrovasc Dis. 2009;27 Suppl 1:111-9. doi: 10.1159/000200448. Epub 2009 Apr 3.

New anticoagulants for atrial fibrillation.

J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):446-53. doi: 10.2459/JCM.0b013e3283249aee.

Novel anticoagulants and the future of anticoagulation.

Thromb Res. 2009;123 Suppl 4:S50-5. doi: 10.1016/S0049-3848(09)70144-6.

[Rivaroxaban: mode of action].

Ann Fr Anesth Reanim. 2008 Dec;27 Suppl 3:S9-15. doi: 10.1016/S0750-7658(08)75141-4.

引用本文的文献

New anticoagulants for the treatment of venous thromboembolism.

J Bras Pneumol. 2016 Apr;42(2):146-54. doi: 10.1590/S1806-37562016042020068.

Anticoagulation in Atrial Fibrillation.

Arrhythm Electrophysiol Rev. 2012 Sep;1(1):12-16. doi: 10.15420/aer.2012.1.12.

New oral anticoagulants may be particularly useful for asian stroke patients.

J Stroke. 2014 May;16(2):73-80. doi: 10.5853/jos.2014.16.2.73. Epub 2014 May 30.

Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs.

Thromb J. 2014 Mar 21;12(1):7. doi: 10.1186/1477-9560-12-7.

[New oral anticoagulants: better than vitamin K antagonists?].

Internist (Berl). 2010 Dec;51(12):1571-81. doi: 10.1007/s00108-010-2725-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The clinical implications of new oral anticoagulants: will the potential advantages be achieved?

Thromb Haemost. 2010 Jan;103(1):34-9. doi: 10.1160/TH09-06-0361. Epub 2009 Dec 1.

Bleeding complications in patients on anticoagulants who would have been disqualified for clinical trials.

Thromb Haemost. 2008 Dec;100(6):1047-51.

Does a longer duration of oral factor Xa therapy increase the risk of bleeding or transaminitis?

Thromb Res. 2011 Mar;127(3):202-9. doi: 10.1016/j.thromres.2010.11.017. Epub 2010 Dec 14.

Novel oral anticoagulants and diet: the potential for interaction.

Am J Hematol. 2009 Apr;84(4):260-1. doi: 10.1002/ajh.21371.

New oral anticoagulants in development.

Thromb Haemost. 2010 Jan;103(1):62-70. doi: 10.1160/TH09-07-0434. Epub 2009 Oct 26.

Anticoagulant drugs: what is new?

Int Angiol. 2011 Aug;30(4):299-320.

Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.

Cerebrovasc Dis. 2009;27 Suppl 1:111-9. doi: 10.1159/000200448. Epub 2009 Apr 3.

New anticoagulants for atrial fibrillation.

J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):446-53. doi: 10.2459/JCM.0b013e3283249aee.

Novel anticoagulants and the future of anticoagulation.

Thromb Res. 2009;123 Suppl 4:S50-5. doi: 10.1016/S0049-3848(09)70144-6.

[Rivaroxaban: mode of action].

Ann Fr Anesth Reanim. 2008 Dec;27 Suppl 3:S9-15. doi: 10.1016/S0750-7658(08)75141-4.

引用本文的文献

New anticoagulants for the treatment of venous thromboembolism.

J Bras Pneumol. 2016 Apr;42(2):146-54. doi: 10.1590/S1806-37562016042020068.

Anticoagulation in Atrial Fibrillation.

Arrhythm Electrophysiol Rev. 2012 Sep;1(1):12-16. doi: 10.15420/aer.2012.1.12.

New oral anticoagulants may be particularly useful for asian stroke patients.

J Stroke. 2014 May;16(2):73-80. doi: 10.5853/jos.2014.16.2.73. Epub 2014 May 30.

Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs.

Thromb J. 2014 Mar 21;12(1):7. doi: 10.1186/1477-9560-12-7.

[New oral anticoagulants: better than vitamin K antagonists?].

Internist (Berl). 2010 Dec;51(12):1571-81. doi: 10.1007/s00108-010-2725-z.